Market Overview:
The global preclinical imaging market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for early and accurate diagnosis of diseases, technological advancements in preclinical imaging systems, and rising number of research and development activities. Based on type, the global preclinical imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic Imaging Systems (PAIS), and preclinical magnetic particle Imaging (MPI) Systems. The optical imaging system segment is expected to account for the largest share of the global preclinical imaging market in 2018. This can be attributed to its growing popularity among researchers owing to its noninvasive nature and ability to provide high-resolution images with good contrast resolution. Based on application, hospitals are expected account for the largest share of the globalpre clinical im aging m arket i n 2 0 2 8 . T his c an b e a tt r ib ut ed t o th e g ro wing num ber o f h os p ita ls ac ro ss th e w or ld an d th e ir need fo r adva nc ed te chnolo gy fo r dia gnos ti cs an d tre atm en t .
Product Definition:
Preclinical Imaging is the use of various imaging technologies to visualize organs, tissues and whole organisms in their natural state or after being altered by experimental manipulations. Preclinical Imaging is important because it can help researchers learn about how a disease progresses, identify potential drug targets and test new treatments.
Optical Imaging Systems:
Optical imaging systems are the devices that use light to create images of biological tissues and organs. These systems can be used in various applications such as medical diagnosis, research studies, drug discovery & development, preclinical toxicity testing and clinical trials. The optical imaging market is expected to grow at a lucrative rate during the forecast period due to its increasing usage in Preclinical studies especially for toxicology purposes by researchers & scientists which will further help in developing new drugs with reduced side effects.
Nuclear Imaging Systems:
Nuclear imaging systems are used for the noninvasive study of disease progression at early stages. These devices produce images of body organs and tissues in real-time, without any harmful radiation exposure. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes is expected to boost the demand for preclinical nuclear imaging systems over the forecast period.
Application Insights:
The others segment dominated the global preclinical imaging market in 2017, accounting for over 40% of the overall revenue share. The other applications include research institutes and industrial facilities. Preclinical imaging systems are widely used by researchers and scientists at various research institutions across the world for their studies. These systems help them to understand the biological effects of drugs or treatments on living tissues in order to optimize drug development process as well as treatment procedures before introducing them into clinical trials.
Preclinical MRI is widely preferred due to its ability to provide detailed information about tissue organization, composition, and dynamics within a matter of minutes with no damage or risk involved towards animals compared with conventional techniques such as X-ray microtomography which requires an invasive procedure that involves surgery followed by days spent under observation in a hospital environment after completion of experimentally induced disease state in animal model organisms (models).
Regional Analysis:
North America dominated the global preclinical imaging market in 2016. This can be attributed to the presence of a large number of players, high adoption rate for advanced technologies, and increasing R&D activities in this region. Moreover, growing preference for on-site diagnostic facilities by companies is also driving demand over here.
The key players operating in this industry are GE Healthcare; Siemens Healthineers; PerkinElmer Inc.; Hitachi, Ltd.; Philips Healthcare; Koninklijke Philips N.V.; Carestream Health; Abbott Laboratories; Bio-Rad Laboratories Inc.; Amgen Incorporated; FUJIFILM Diosynth Biotechnologies UAB., LLC., Roche Diagnostics Corporation Genentech USA Holdings, LLC., and Thermo Fisher Scientific Inc.
Growth Factors:
- Increasing demand for novel drugs and therapies: The Preclinical Imaging market is expected to grow in response to the increasing demand for novel drugs and therapies. This is due to the fact that preclinical imaging helps researchers understand how a drug will work in humans by providing images of organs, tissues, and cells.
- Advances in technology: The Preclinical Imaging market is expected to grow due to advances in technology, which are making it easier and faster to create images of organs, tissues, and cells. This allows researchers to get a better understanding of how a drug will work in humans.
- Growing focus on personalized medicine: There is growing focus on personalized medicine, which relies on preclinical imaging data to help customize treatments for individual patients. This is because preclinical imaging can help identify genetic variations that may affect how a drug works within an individual patient’s body.
Scope Of The Report
Report Attributes
Report Details
Report Title
Preclinical Imaging Market Research Report
By Type
Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
By Application
Hospitals, Diagnostics Centers, Others
By Companies
Perkinelmer, Bruker, Fujifilm, Mediso, Milabs, MR Solutions, Aspect Imaging, Li-Cor Biosciences, Trifoil Imaging, Miltenyi Biotec, Perkinelmer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
187
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Preclinical Imaging Market Report Segments:
The global Preclinical Imaging market is segmented on the basis of:
Types
Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostics Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Perkinelmer
- Bruker
- Fujifilm
- Mediso
- Milabs
- MR Solutions
- Aspect Imaging
- Li-Cor Biosciences
- Trifoil Imaging
- Miltenyi Biotec
- Perkinelmer
Highlights of The Preclinical Imaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Optical Imaging Systems
- Nuclear Imaging Systems
- Micro-MRI Systems
- Micro-Ultrasound Systems
- Micro-CT Systems
- Preclinical Photoacoustic Imaging Systems
- Preclinical Magnetic Particle Imaging (MPI) Systems
- By Application:
- Hospitals
- Diagnostics Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Preclinical Imaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Preclinical imaging is the use of imaging techniques to study the effects of drugs or other treatments in animals before they are administered to humans.
Some of the major companies in the preclinical imaging market are Perkinelmer, Bruker, Fujifilm, Mediso, Milabs, MR Solutions, Aspect Imaging, Li-Cor Biosciences, Trifoil Imaging, Miltenyi Biotec, Perkinelmer.
The preclinical imaging market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Preclinical Imaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Preclinical Imaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Preclinical Imaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Preclinical Imaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Preclinical Imaging Market Size & Forecast, 2018-2028
4.5.1 Preclinical Imaging Market Size and Y-o-Y Growth
4.5.2 Preclinical Imaging Market Absolute $ Opportunity
Chapter 5 Global Preclinical Imaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Preclinical Imaging Market Size Forecast by Type
5.2.1 Optical Imaging Systems
5.2.2 Nuclear Imaging Systems
5.2.3 Micro-MRI Systems
5.2.4 Micro-Ultrasound Systems
5.2.5 Micro-CT Systems
5.2.6 Preclinical Photoacoustic Imaging Systems
5.2.7 Preclinical Magnetic Particle Imaging (MPI) Systems
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Preclinical Imaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Preclinical Imaging Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostics Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Preclinical Imaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Preclinical Imaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Preclinical Imaging Analysis and Forecast
9.1 Introduction
9.2 North America Preclinical Imaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Preclinical Imaging Market Size Forecast by Type
9.6.1 Optical Imaging Systems
9.6.2 Nuclear Imaging Systems
9.6.3 Micro-MRI Systems
9.6.4 Micro-Ultrasound Systems
9.6.5 Micro-CT Systems
9.6.6 Preclinical Photoacoustic Imaging Systems
9.6.7 Preclinical Magnetic Particle Imaging (MPI) Systems
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Preclinical Imaging Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostics Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Preclinical Imaging Analysis and Forecast
10.1 Introduction
10.2 Europe Preclinical Imaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Preclinical Imaging Market Size Forecast by Type
10.6.1 Optical Imaging Systems
10.6.2 Nuclear Imaging Systems
10.6.3 Micro-MRI Systems
10.6.4 Micro-Ultrasound Systems
10.6.5 Micro-CT Systems
10.6.6 Preclinical Photoacoustic Imaging Systems
10.6.7 Preclinical Magnetic Particle Imaging (MPI) Systems
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Preclinical Imaging Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostics Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Preclinical Imaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Preclinical Imaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Preclinical Imaging Market Size Forecast by Type
11.6.1 Optical Imaging Systems
11.6.2 Nuclear Imaging Systems
11.6.3 Micro-MRI Systems
11.6.4 Micro-Ultrasound Systems
11.6.5 Micro-CT Systems
11.6.6 Preclinical Photoacoustic Imaging Systems
11.6.7 Preclinical Magnetic Particle Imaging (MPI) Systems
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Preclinical Imaging Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostics Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Preclinical Imaging Analysis and Forecast
12.1 Introduction
12.2 Latin America Preclinical Imaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Preclinical Imaging Market Size Forecast by Type
12.6.1 Optical Imaging Systems
12.6.2 Nuclear Imaging Systems
12.6.3 Micro-MRI Systems
12.6.4 Micro-Ultrasound Systems
12.6.5 Micro-CT Systems
12.6.6 Preclinical Photoacoustic Imaging Systems
12.6.7 Preclinical Magnetic Particle Imaging (MPI) Systems
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Preclinical Imaging Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostics Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Preclinical Imaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Preclinical Imaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Preclinical Imaging Market Size Forecast by Type
13.6.1 Optical Imaging Systems
13.6.2 Nuclear Imaging Systems
13.6.3 Micro-MRI Systems
13.6.4 Micro-Ultrasound Systems
13.6.5 Micro-CT Systems
13.6.6 Preclinical Photoacoustic Imaging Systems
13.6.7 Preclinical Magnetic Particle Imaging (MPI) Systems
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Preclinical Imaging Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostics Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Preclinical Imaging Market: Competitive Dashboard
14.2 Global Preclinical Imaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Perkinelmer
14.3.2 Bruker
14.3.3 Fujifilm
14.3.4 Mediso
14.3.5 Milabs
14.3.6 MR Solutions
14.3.7 Aspect Imaging
14.3.8 Li-Cor Biosciences
14.3.9 Trifoil Imaging
14.3.10 Miltenyi Biotec
14.3.11 Perkinelmer
